Business
Encompass Compliance Corporation (ENCC) and Madison Avenue Drug Testing Sign a Channel Sales Agreement
Encompass Compliance Corporation (ENCC) and Madison Avenue Drug Testing Sign a Channel Sales Agreement.
About this update from Encompass Compliance Corp.
[{"type":"text","content":"\n\n\n\nEncompass Compliance Corporation (ENCC) and Madison Avenue Drug Testing Sign a Channel Sales Agreement\n\n\n\n\n\nEncompass Compliance Corporation (ENCC) and Madison Avenue Drug Testing Sign a Channel Sales Agreement\nPR Newswire\nCHARLOTTE, North Carolina, March 16, 2017\n\n\n\nCHARLOTTE, North Carolina, March 16, 2017 /PRNewswire/ --\n\nEncompass Compliance Corp. (OTC PINK:ENCC) announces a channel sales agreement with Madison Avenue Drug Testing.\n\nEncompass Compliance Corp. is the most comprehensive provider of workplace drug and alcohol testing compliance services, with over 30 years of experience. We are dedicated to providing employers with the tools necessary to mitigate regulatory and compliance risk. Our solutions provide organizations with up-to-date policies, a comprehensive resource center and real-time monitoring for drug and alcohol testing orders.\n\nMadison Avenue Drug Testing (http://madisonavenueproducts.com) is a premier provider of drug testing products to corporations throughout the U.S. They provide products that test for: THC, alcohol, cocaine, amphetamines, methamphetamines, opiates, benzodiazepines, propoxyphene, PCP, oxycodone, morphine, ecstasy, methadone, buprenorphine, barbiturates, ketamine, K2, tramadol, ETG. \"As a supplier of drug testing products to over 3,000 companies, they are a natural fit to provide our Risk Shield Compliance services to their customers,\" says Encompass CEO, Richard Sharp.\n\nMadison Avenue Drug Testing CEO Keith Devine says, \"We feel extremely fortunate to be selected by Encompass Inc. as a channel partner. Combining the best legal minds in the business with our diverse clientele, instills confidence in our customers that they are provided the most comprehensive state specific compliance solutions available.\"\n\nThere will be joint marketing activities such as webinars, regular mailings and updates on a regular basis to Madison Avenue Drug Testing Customers.\n\nSafe Harbor Statement:\n\nThis press release may include predictions, estimates, opinions or statements that might be considered \"forward-looking\" under the provisions of the Private Securities Litigation Reform Act of 1995. Statements generally identified by phrases such as the Company or its management \"believes,\" \"expects,\" \"forecasts,\" \"estimates,\" or other words or phrases ...